Correspondence to Dr Douglas J Wiebe, Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA; dwiebe{at}upenn.edu Objective To examine the progression of ...
Impact of life-sustaining therapies on critically ill patients with cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.
Different degree of response to checkpoint inhibitors in metastatic NSCLC patients according to mutations within KRAS gene. Mature progression-free survival (PFS) milestones in real world stage IV, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback